Management of type I gastric-neuroendocrine tumors: the less the better?
Present data confirm an indolent behavior for type I gNETs. Preoperative EUS staging led to a change in the management in one case, which highlights the need of dedicated studies to identify predictive factors to stratify risk and plan the management of these neoplasms.
Authors
- Silvia Uccella (ORCID: https://orcid.org/0000-0002-5714-7295)
- Cesare Hassan (ORCID: https://orcid.org/0000-0001-7167-1459)
- Andrea Lania (ORCID: https://orcid.org/0000-0002-5380-2141)
- Alessandro Repici (ORCID: https://orcid.org/0000-0002-1621-6450)
- Roberta Elisa Rossi (ORCID: https://orcid.org/0000-0003-4208-4372)
- Benedetta Masoni
- Alexia Bertuzzi (ORCID: https://orcid.org/0000-0002-8933-9929)
- Silvia Carrara (ORCID: https://orcid.org/0000-0003-4206-9463)
- Alessandro Zerbi (ORCID: https://orcid.org/0000-0002-9176-0448)
- Valeria Poletti (ORCID: https://orcid.org/0000-0002-4168-8660)
- Roberta Maselli (ORCID: https://orcid.org/0000-0001-7291-9110)
Institutions
- Humanitas University (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3389/fendo.2025.1666699
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35